US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Warimpex Finanzund Beteillgungs Ag (0O0P) 銘柄情報

Warimpex Finanzund Beteillgungs Ag (0O0P)

1.43

0.00

(0.00%)

終了 6月23日 12:30AM

Warimpex Finanzund Beteillgungs Ag (0O0P) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.43

( - )

買値

1.43

売値

1.43

出来高

0.00

0.00 日の範囲 0.00

1.43 52 週間の範囲 1.43

時価総額

前日終値

1.43

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

14,651 €

発行済株式数

52,060,720

配当利回り

PER

-10.56

1 株当たり利益 (EPS)

-0.05

歳入

20.43M

純利益

-2.42M

Warimpex Finanz- und Beteiligungs AG operates as a real estate development and investment company in Austria, Germany, Hungary, and Poland. It operates through Investment Properties, Hotels, and Development and Services segments. The company is involved in the construction, purchase, refurbishment, ... Warimpex Finanz- und Beteiligungs AG operates as a real estate development and investment company in Austria, Germany, Hungary, and Poland. It operates through Investment Properties, Hotels, and Development and Services segments. The company is involved in the construction, purchase, refurbishment, and operation of offices and hotel properties. It also provides tenant adaptations and renting of property; lodging, and food and beverages; and asset management services. In addition, it is involved in the sale of developed properties; and services for third parties. It serves corporate, business, and leisure customers, as well as sales channels. The company was founded in 1959 and is headquartered in Vienna, Austria. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.warimpex.com

本社

Vienna, Austria

設立

2026

Warimpex Finanzund Beteillgungs Ag is listed in the sector of the ロンドン証券取引所 with ticker 0O0P. The last closing price for Warimpex Finanzund Betei... was 1.43 €. Over the last year, Warimpex Finanzund Betei... shares have traded in a share price range of 1.43 € to 1.43 €.

Warimpex Finanzund Betei... currently has 52,060,720 shares in issue. The market capitalisation of Warimpex Finanzund Betei... is 74.45 € million. Warimpex Finanzund Betei... has a price to earnings ratio (PE ratio) of -10.56.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	1.43	1.43	1.43	0	0	DE
52	0	0	1.43	1.43	1.43	0	0	DE
156	0	0	1.43	1.43	1.43	0	1.43	DE
260	0	0	1.43	1.43	1.43	3	1.43	DE

0O0P - Frequently Asked Questions (FAQ)

What is the current Warimpex Finanzund Beteillgungs Ag share price?

The current share price of Warimpex Finanzund Beteillgungs Ag is 1.43 €

How many Warimpex Finanzund Beteillgungs Ag shares are in issue?

Warimpex Finanzund Beteillgungs Ag has 52,060,720 shares in issue

What is the market cap of Warimpex Finanzund Beteillgungs Ag?

The market capitalisation of Warimpex Finanzund Beteillgungs Ag is EUR 74.45M

What is the 1 year trading range for Warimpex Finanzund Beteillgungs Ag share price?

Warimpex Finanzund Beteillgungs Ag has traded in the range of 1.43 € to 1.43 € during the past year

What is the PE ratio of Warimpex Finanzund Beteillgungs Ag?

The price to earnings ratio of Warimpex Finanzund Beteillgungs Ag is -10.56

What is the cash to sales ratio of Warimpex Finanzund Beteillgungs Ag?

The cash to sales ratio of Warimpex Finanzund Beteillgungs Ag is 1.35

What is the registered address of Warimpex Finanzund Beteillgungs Ag?

The registered address for Warimpex Finanzund Beteillgungs Ag is Floridsdorfer Hauptstrasse 1, Vienna, Vienna, 1210

What is the Warimpex Finanzund Beteillgungs Ag website address?

The website address for Warimpex Finanzund Beteillgungs Ag is www.warimpex.com

John Doe 2024

John Doe 2024 41秒前

We don't have the money to be entertaining another shitshow!

jour_trader

jour_trader 2分前

At this point, Nasrat’s vote is the only one that counts until institutional ownership is able to buy in.

ron_66271

ron_66271 4分前

Great ND9. But WMB Never Failed!

The media told us that WMB failed.
The media is hear say evidence, and not admissible evidence to the court of law.

The FDIC’s numbers;
$298 Billion for WMB and its assets.

Ron

learningcurve2020

learningcurve2020 5分前

All mega doses of B vitamins have been considered for a long time.

Biotech_Tradez

Biotech_Tradez 5分前

He might have run into issues with the SEC as he was in some ways obviously breaking securities laws in the way he was trying to raise capital and how he had insider knowledge and leaked it to BIEL pumpers and then posted it to the board in order to curry favor with them to entice them into investin

learningcurve2020

learningcurve2020 8分前

Maybe $10 Niacin with adjuvant $300,000 DCVAX?🙄

webtex 44

webtex 44 9分前

When the last executive was hired, they stated that they would be hiring three more executives. I think these new hires will be people with experience running a Milling and POX operation or Roasting operation, which ever one they settle on. I think one will be a CEO with a background in building the

ghostandgurgi

ghostandgurgi 13分前

We will get the dividend; they are on the books for SNTX already. Just depends how long the company takes to issue them. Should have been done by now, but we wait.

US Market News

US Market News 13分前

AIxCrypto Debuts at Automate 2026, Unveiling Its EAI + Web3 Robot Ecosystem Strategy with the Launch of RoboShare and AIXC01June 22, 2026 10:00 PM
PR Newswire (US) At Automate 2026 in Chicago, the Nasdaq-listed company launches RoboShare — a matchmaking

ron_66271

ron_66271 15分前

The AI Questions need to be Very Definitive.

Example;
We have documentation that the $1.9 Billion paid by JPM to the FDIC for WMB was an administration fee based on 1% of the deposits of WMB.

? Can you verify this ?

NEXT ?
WMI sued t

Yachts

Yachts 15分前

Moreover, where are the current financials? This all feels like a lot of sawdust, but no lumber.

learningcurve2020

learningcurve2020 15分前

Wow, that’s about as wrong as it gets!

>>It can't be sufficiently effective, long term, without identifying and attacking ALL of the antigens associated with the cancer.

monty.ce

monty.ce 18分前

Yes, it could be institutional. Retail traders tend to be most active at the open and close. And it's better to spread purchases across multiple days to draw little attention. It also keeps the price relatively stable so they can keep buying at attractive levels.

So agreed, it could

bas2020

bas2020 19分前

It can't be sufficiently effective, long term, without identifying and attacking ALL of the antigens associated with the cancer... like DCVax does. Regardless of what "LearingCurve" spins.

Hoskuld

Hoskuld 20分前

Good luck to the patients. But, if this works in these patients then it will be fast-tracked a la gleevec. This is not a Phase 1 where they are simply dosing healthy volunteers, they are dosing mortally ill patients where the was evidence previously of 100% effectiveness. Compare this to NWBO's t

georgejjl

georgejjl 20分前

Alan Greenspan died today!!!

https://www.reuters.com/world/us/alan-greenspan-economist-longtime-head-federal-reserve-dies-100-nbc-news-reports-2026-06-22/

GOD bless, 🙏

JusDePomme

JusDePomme 21分前

Same accumulated some more cheap shares today

PantyPuller

PantyPuller 22分前

Well taki for once I absolutely agree with you...it's time

WALL STREET KID

WALL STREET KID 22分前

$AMC NEXT PRICE TARGET! NEW RECORD AGAIN!

https://youtu.be/LFZSxInUu-s?si=KqBx8ehPsmna6WAT

https://x.com/CEOAdam/status/2069062883489529919

DrivenByPain

DrivenByPain 23分前

$SNTX! IMO ! Information Is To Sensitive For X Posting Now .🤑 Go To The OTC Page From Here On Up . 🤠

misterfishman

misterfishman 24分前

Our time will come.

misterfishman

misterfishman 25分前

All good things in due time.

improving

improving 26分前

You may have called this one a little too soon -Phase 1 wrapping up at years end in 2027.
Brief Summary:
This is a Phase I study to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in adult patients with recurren

Warimpex Finanzund Betei...

Chunghwa Telecom

Xtrackers II Target Matu...

Minotfccbfrn Bonds

ML Capital (EM)

CocaCola European Partners

4.917% Nts 25/09/33 144a

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。